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Abstract
Background: We aimed to investigate and optimise the acceptability and usefulness of a patient leaflet about
antibiotic prescribing decisions made during hospitalisation, and to explore individual patient experiences and
preferences regarding the process of antibiotic prescription ‘review and revise’ which is a key strategy to minimise
antibiotic overuse in hospitals.
Methods: In this qualitative study, run within the feasibility study of a large, cluster-randomised stepped wedge
trial of 36 hospital organisations, a series of semi-structured, think-aloud telephone interviews were conducted and
data were analysed using thematic analysis. Fifteen adult patients who had experienced a recent acute medical
hospital admission during which they had been prescribed antimicrobials and offered a patient leaflet about
antibiotic prescribing were recruited to the study.
Results: Participants reacted positively to the leaflet, reporting that it was both an accessible and important source
of information which struck the appropriate balance between informing and reassuring. Participants all valued open
communication with clinicians, and were keen to be involved in antibiotic prescribing decisions, with individuals
reporting positive experiences regarding antibiotic prescription changes or stopping. Many participants had prior
experience or knowledge of antibiotics and resistance, and generally welcomed efforts to reduce antibiotic usage.
Overall, there was a feeling that healthcare professionals (HCPs) are trusted experts providing the most appropriate
treatment for individual patient conditions.
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Conclusions: This study offers novel insights into how patients within secondary care are likely to respond to
messages advocating a reduction in the use of antibiotics through the ‘review and revise’ approach. Due to the
level of trust that patients place in their care provider, encouraging HCPs within secondary care to engage patients
with greater communication and information provision could provide great advantages in the drive to reduce
antibiotic use. It may also be beneficial for HCPs to view patient experiences as cumulative events that have the
potential to impact future behaviour around antibiotic use. Finally, pre-testing messages about antibiotic
prescribing and resistance is vital to dispelling any misconceptions either around effectiveness of treatment for
patients, or perceptions of how messages may be received.
Trial registration: Current Controlled Trials ISRCTN12674243 (10 April 2017),
Keywords: Antibiotic prescribing, Hospital patients, Antimicrobial stewardship
Background
Antimicrobial resistance (AMR) is an important issue
patients worldwide, with impacts on both healthcare
costs and patient safety [1]. Over prescribing of antimi-
crobials contributes significantly to the growing problem
of AMR worldwide [2]. Up to 50% of antibiotic prescrib-
ing may be inappropriate either because antibiotics are
not indicated or the agent(s) selected are too broad or
continued longer than needed [3–5]. In primary care, ef-
forts to minimise antibiotic overuse are directed at only
starting antibiotic treatment when there is a clear clin-
ical reason to do so [6]. In secondary care, where pa-
tients are more acutely unwell, strategies to optimise
antibiotic use involve prompt empiric antibiotic therapy
while there is diagnostic uncertainty, followed by regular
review and revise to target and where appropriate, stop
antibiotic treatment. In the NHS (National Health
Service), this strategy is set out in Department of Health
guidance, ‘Start Smart then Focus’ [7]. Start Smart then
Focus recommends five decisions prescribers can take
reviewing antibiotic therapy: stop, continue, move IV to
oral, broaden or de-escalate or move to outpatient intra-
venous therapy. However, controlling antibiotic overuse
through review and revise is challenging [8–10].
Antibiotic Review Kit (ARK) Hospital is a complex
behavioural intervention targeting all healthcare profes-
sionals (HCPs) involved in prescribing, dispensing or ad-
ministering antibiotics for acute and general medicine
adult patients. This paper reports the findings of a set of
interviews with patients as part of the wider develop-
mental and feasibility work for a full-scale RCT (rando-
mised controlled trial) aiming to encourage appropriate
and timely stopping of antibiotics that are no longer
needed. The overall intervention incorporates digital, be-
havioural and organisational elements, including online
training, a decision aid tool to support decision-making
around antibiotic prescriptions, a patient information
leaflet, a structure for monitoring and discussing imple-
mentation of the intervention, detailed implementation
guidance, a resources website and a peer support
network [11]. For the feasibility trial, all intervention ele-
ments were implemented in one medium-sized acute
hospital in the UK. Full details of how ARK was used by
healthcare professionals during the study are available in
a separate publication [12]. The qualitative study de-
scribed here was an investigation of the feasibility and
acceptability of the patient leaflet element of the inter-
vention among patients at the feasibility study site. This
paper details the development and optimisation of the
leaflet. The full protocol for the main trial is reported
elsewhere [13].
Evidence from primary care suggests that engaging pa-
tients in antibiotic-prescribing decisions can facilitate re-
ducing antibiotic use [14]. In secondary care, while there
is evidence that both patients and clinicians want an in-
crease in shared decision-making around prescribing
[15, 16], it is not yet clear whether this shared decision-
making could lead to similar reductions in antibiotic use
[17]. As a result, the ARK-Hospital information leaflet
aimed to reassure, inform and empower patients about
potential changes made to their antibiotic prescription.
However, there is an absence of research evidence to in-
form the design and use of a patient information leaflet
to support the antibiotic ‘review and revise’ prescribing
process within secondary care.
The aim of this qualitative study was to investigate
and optimise the acceptability and usefulness of such a
patient leaflet in secondary care, ahead of intended use
in a full-scale RCT. We also aimed to explore and
understand individual patient experiences of the ‘review
and revise’ process and identify patient views and prefer-
ences regarding antimicrobial treatment in hospitals to
inform both the larger trial and any future research in
this field.
Methods
Developing the patient information leaflet
The detail and planning of the ARK-Hospital interven-
tion are described elsewhere [11]. The patient leaflet was
developed iteratively, building initially on previous
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research (GRACE-INTRO) which drew on theory and
qualitative user feedback as detailed elsewhere [18] and
was designed to be understood by readers with lower
levels of health literacy. This was further refined by
health psychologists and clinicians to ensure accuracy of
the health messages. Feedback was sought from project
stakeholders and from members of a public and patient
involvement (PPI) group. This feedback included sugges-
tions for ways to improve the look and feel of the leaflet,
e.g. by incorporating more engaging images, simplifying
the layout and making minor clarifications to the text.
PPI input was particularly useful in ensuring that the
leaflet gave relevant, but accessible information about
antibiotic resistance and how to present this without
causing undue concern. The leaflet provides patients
with brief information about when antibiotics are used,
the possible risks of taking antibiotics, the ‘review and
revise’ process and advice about what to do when their
antibiotics are stopped.
Recruitment
Ethical approval for the ARK-Hospital implementation
study (ISRCTN: 12674243) was obtained from the
National Research Ethics Committee (REC reference 17/
SC/0034), including feasibility, pilot and main trial
phases. It is useful to note that for the feasibility, pilot
and main trials, neither staff, nor patients are individu-
ally consented into the study as the overall unit of ran-
domisation and analysis is the site or trust and no data
is identifiable. Only for qualitative date collection did we
consent staff or patients. As such, participants for this
qualitative component were recruited as a convenience
sample from patients admitted through the Acute
Medical Unit (AMU) at the feasibility study site (the
Royal Sussex County Hospital, Brighton) between June
2017 and February 2018. All participants had been pre-
scribed antibiotics during their hospital stay. For most
patients, the intervention leaflet was given to patients at
their time of discharge from hospital, though in a few
cases patients received the leaflet when a change had
been made to their antibiotic prescription. In line with
ethics requirements, participants were identified and in-
vited to take part in the study at the time of discharge
by medical staff who introduced the study and provided
them with a study information sheet explaining that par-
ticipation was both confidential and voluntary. Medical
staff also checked that the participant had been given a
copy of the leaflet and asked them to keep this for the
interview. Interested participants completed the consent
form and provided contact details to the member of
medical staff who then posted these details to re-
searchers at the University of Southampton. Researchers
then contacted participants to arrange an interview and
verbal consent and demographic data were collected
prior to each interview. A total of 125 patients were
approached about the study, with 25 providing consent
to be contacted by a researcher. Of these 25 patients, 10
dropped out, either because they no longer wanted to
take part by the time of interview, or because they could
not be contacted. This left a total of 15 study
participants.
Interviews
The study methodology involved semi-structured, think-
aloud [19], telephone interviews, which lasted between
20 and 30 min. These were conducted by FM and KS,
who are PhD qualified, research fellows with training
and experience of qualitative methods in health research,
including conducting cognitive interviews. The study
participants were not acquainted with the researchers
prior to the study, but they were informed about the
purpose of the study and were made aware that the re-
searchers were affiliated with University of Southamp-
ton. Participants were initially asked a series of open
questions to explore their experience and perception of
the ‘review and revise’ process, including any changes
that were made to their antibiotic prescription and per-
ceptions about the duration of antibiotic treatment.
They were then asked to read, or listen to the inter-
viewer read, the patient leaflet (Fig. 1) that they had re-
ceived while in hospital or at the time of discharge.
Participants were asked to say everything that they were
thinking out loud while they read the leaflet. Several
more open-ended questions followed, which explored
what participants liked or disliked about the leaflet, what
they viewed as most relevant, and any suggested changes
to improve the leaflet. Using a think aloud methodology
enabled us to explore participant reactions to the leaflet
and gain detailed feedback about each aspect of the
intervention, allowing us to make changes to and opti-
mise the content. As negative feedback is especially help-
ful in developing the most effective messages, we
deliberately elicited this within our study. After an initial
nine interviews, the leaflet was revised (Fig. 2) based on
participants’ feedback before being tested with a further
6 participants, for a total of 15 unique participant inter-
views. Participants were compensated with a £10 shop-
ping voucher for taking part in the study.
Data analysis
Interviews were audio recorded and transcribed verba-
tim. No field notes were made by researchers either dur-
ing or after the interviews and transcripts were not
returned to participants. Analysis initially focused on
identifying any potential barriers to use of the leaflet and
interview feedback was used to identify any areas where
changes might make it more acceptable, engaging or
useful. Each transcript was reviewed line-by-line to draw
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out all responses that were either positive or negative
perceptions of the leaflet [20]. Responses were tabulated
and each negative comment was reviewed to determine
whether a change was necessary. If so, the solution was
recorded in the table, discussed with the wider team and
the change was made. Changes were made if they were
likely to impact on the acceptability of the leaflet or the
‘review and revise’ process. This included exploring
aspects such as whether the information was perceived
as convincing, reassuring and comprehensible. The
MoSCoW (must have, should have, could have, would
have) criteria were used to assess priority [20] and each
change was made in line with the common and interven-
tion specific guiding principles of the person-based ap-
proach [21]. Although similar to content analysis, the
table of changes as illustrated below, has been created
specifically for use in intervention development. As such,
it does not aim to quantify qualitative data, but instead
offers a way to analyse this intervention feedback in a
systematic and efficient manner, often running in paral-
lel with in depth thematic analysis [21]. An example of
the data tabulation is shown in Table 1.
Each transcript also underwent inductive thematic
analysis [22], supported by use of the QSR NVivo 11
software, and was coded into emerging themes, which
represented frequent patterns of meaning within the
dataset. Coding followed the aims of the research, focus-
ing on patients’ experiences and perceptions of the ‘re-
view and revise’ process and the acceptability of a
patient leaflet. Coding was done by FM, an experienced
qualitative researcher, with KS reviewing transcripts and
codes frequently and advising on the development of
themes. The final themes were agreed upon by the re-
search team through discussion and consensus that sat-
uration had been reached based on the completion of 15
interviews. Data collection stopped when no new con-
cerns or themes emerged.
Results
Ten (67%) women and five (33%) men participated, with
an age range of 50–91 and mean age of 72 (SD = 13.2).
All participants spoke English as their first language and
reported their cultural background as British. Partici-
pants had all been discharged from hospital and eight
Fig. 1 Original version of leaflet text
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(53%) were still taking antibiotics at the time of dis-
charge. Full demographic details are available in Table 2.
Following detailed thematic analysis, 34 subcategories
that fell into 12 categories were extracted from the tran-
scripts. From these, 4 interlinking themes were identified
(Table 3). The participants described their perceptions of
the leaflet and the impact that it had on their views of
treatment. This led to discussions about their largely posi-
tive experiences of the ‘review and revise’ process, while
also linking to any existing knowledge of antibiotics and
antibiotic resistance. Finally, participants all described the
trust that they place in HCPs to make treatment decisions,
which appeared to mitigate any potential concerns around
prescriptions being changed or stopped.
This data is an extract of quotes derived from thematic
analysis of interviews exploring participants’ experiences
of the ‘review and revise’ process and provision of an in-
formation leaflet in secondary care.
Fig. 2 Final version of leaflet text following revisions. Highlighting indicates areas where text was altered as a result of qualitative data and
PPI input
Table 1 Example of table of iterative changes made to patient leaflet
Page or aspect
of the intervention
Positive
comments
Negative comments Possible change Reason for change Agreed change MoSCoW
Section titled:
‘What are the risks
of taking antibiotics?’
Confusion over how
antibiotic resistant
bacteria can be
spread to others,
e.g. ‘I didn’t realise
that antibiotic
resistance can
spread to other
members of the
family. I’m not
quite sure what
it means.’
Explanation of
spreading antibiotic
resistant bacteria
to others made
clearer.
Important to behaviour
change as we do not
want to confuse or
concern patients.
Expert clinicians
and health psychologists
agreed the change
was suitable.
Repeatedlymentioned
by participants.
Changed bolded
text to reduce any
concerns and
clarified text about
passing on
resistance to others.
Must have, crucial
to ensure patients
accurately understand
the risks of antibiotics.
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Leaflet acceptability and impact on perceptions of
treatment
During initial interviews, several participants had ques-
tions or concerns regarding antibiotic resistance, par-
ticularly how this can be spread to others. For most, this
stemmed from a lack of awareness that resistance can be
passed on and a lack of clarity about how this happens:
I didn’t realise that resistance could spread to
others…I’m not quite sure what that means, how
can it spread…I don’t understand that. (patient 2,
female, 65)
We felt that it was important to address these con-
cerns by making minor revisions to the leaflet in con-
sultation with the PPI group. These revisions aimed to
reassure readers that when their doctor prescribes anti-
biotics only when really needed, this helps to reduce the
likelihood of developing (and hence passing on) resist-
ance. Following these revisions, further patient inter-
views indicated that although there was still a lack of
awareness around the spread of resistance, concern
appeared to have been mitigated:
I didn’t realise that antibiotic resistance, you know
by me taking it, it could affect somebody else…it
doesn’t concern me, I just didn’t realise that, but it’s
very easy to understand. (patient 13, female, 74)
Overall, the majority of participants reacted positively
to the leaflet, explaining that they found it ‘informative’
and ‘easy to read’. Several participants also discussed the
importance of being given the information that was
included in the leaflet:
I think it’s a good move to actually inform the public,
not just patients, but the general public. To inform
them about the dangers in the future of antibiotics
not working. (patient 11, male, 77)
The leaflet was given to some participants when anti-
biotics were initially prescribed, and to others only at
the time of discharge from hospital. A couple of partici-
pants who received the leaflet during discharge men-
tioned that they may have found it more useful at the
time of treatment, but the majority felt that it was still of
interest and relevance at the time of discharge. In fact,
all participants reported that they would recommend the
leaflet to others and several explained that they had kept
it to show to family and friends, or as a document that
they could refer back to for further information.
Positive experience of ‘review and revise’ process
Participants all discussed details of their recent stay in
the hospital, and reflected on their experience of the
antibiotic ‘review and revise’ process. Many participants
had been admitted for very serious conditions and spoke
about being unaware of their initial antibiotic prescrip-
tion. Others explained that they were started on antibi-
otics while diagnostic tests were conducted to confirm
their diagnosis. Regardless of awareness of treatment or
a confirmed diagnosis, all participants reported positive
perceptions of the antibiotic prescribing process, often
recognising the importance of receiving fast, initial
treatment:
I was just told it was a precaution because it was
suspected meningitis and obviously I think in that
case they did the right thing, because meningitis is
pretty nasty and can kill. (patient 1, female, 50)
Several participants had experienced changes to their
antibiotic prescription. For some this meant changing to
a different mode of delivery, dosage or drug, while for
others it meant stopping antibiotics altogether. Again, all
Table 2 Demographic characteristics of the sample (n = 15)
Demographic characteristics Number/proportion of the
sample n (%)
Gender
Female 10 (67%)
Male 5 (33%)
Age
18–34 years 0 (0%)
35–54 years 3 (20%)
55–74 years 3 (20%)
> 75 years 9 (60%)
Cultural background
White British/English 15 (100%)
Other 0 (0%)
Education
GCSEs/GNVQs or equivalent 6 (40%)
A-levels 2 (13%)
University degree (e.g. BSc, BA, MSc, PhD) 1 (7%)
No exams taken 6 (40%)
Other 0 (0%)
Languages spoken
English 15 (100%)
Other 0 (0%)
Taking antibiotics when discharged
Yes 8 (53%)
No 5 (33%)
Cannot remember/not sure 2 (13%)
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Table 3 Analytical framework for developing categories and themes for patients’ experiences
Category Definition Example quote
Theme 1: leaflet acceptability and impact on perceptions of treatment
Positive perceptions of review and
revise
Positive feedback given about the leaflet as an
introduction to the ‘review and revise’ process. Also
includes discussion about recommending the leaflet to
others and the overall relevance of the leaflet.
‘I think it makes you feel better knowing that
you’re being checked on and deciding whether
we’re going to need all these antibiotics all the
time.’ (P9, female, 81)
New concerns raised about
resistance
Any concerns or questions that patients discussed
regarding antibiotic resistance as well as how this may
impact friends and family.
‘The one thing that would probably worry me
more than anything is that the more antibiotics
you take the more likely you are to spread them to
other people, such as your family and friends.’ (P3,
male, 78)
Timing of when leaflet received Discussion about perceptions of the impact that timing of
the leaflet had on their input into treatment as well as
perceived relevance of the leaflet.
‘I found that where I had the leaflet it was very
helpful in actually talking to them [HCPs] about what
I was being specifically treated for.’ (P3, male, 78)
Theme 2: experience of review and revise process
Positive perceptions of initial
antibiotic prescribing
Positive perceptions about how antibiotics were initially
prescribed, including reasons for hospitalisation, drug
mode of delivery, awareness (or not) of initial prescription
and any information given about prescription and/or
treatment.
‘…when they put me on the antibiotics they
were telling me exactly what they for, how long I
was going to be on for, and what they was
doing, and if I’ve got any problems with them at
all let them know and they’d stop them.’ (P5,
male, 77)
Experience of prescription changes Feedback about any changes to antibiotic prescription.
Includes discussion about any diagnostic testing and
results, changes to drug mode of delivery and the efficacy
of treatment.
‘They started me on antibiotics and I had about
2 or 3 that day and then 2 in the morning, and
then when they gave me an x-ray they realised it
wasn’t a chest infection, they think it was a viral
infection. So they cancelled the antibiotics.’ (P4,
female, 51)
Patient perceptions of input into
treatment
Amount of input patients felt they had regarding antibiotic
treatment. Reflections on whether they had the
opportunity to ask questions or discuss treatment at the
time of prescribing, or as any changes to treatment were
made, up until the time of discharge.
‘Anything I did want to know, people
automatically told me if I had anything
[medications], which was really good.’ (P14,
female, 83)
Theme 3: existing knowledge of antibiotics
Positive past experience(s) of
antibiotic treatment
Any positive past treatment experiences reported by
patients. It includes aspects of how treatment was
received, but also treatment efficacy.
‘Well obviously, the only thing I use them for is if
you’ve got an infection because then it kills the
infection; it makes you well again. That’s the only
thing I know about antibiotics.’ (P4, female, 51)
Negative past experience(s) of
antibiotic treatment
Any negative past experiences of antibiotic treatment, with
discussion including problems with treatment, particularly
the experience of side effects.
‘I agree that some antibiotics aren’t great, and I
know in the past I’ve had antibiotics that upset
your stomach and had to stop them or change
them. So I’ve said in the past, don’t give me that
one because I don’t like it.’ (P1, female, 50)
Existing concerns about antibiotic
resistance
Patients’ existing knowledge of antibiotic resistance and
the concerns that they had about this.
‘You can get immune to them if you take too
many. I mean it’s pretty obvious, it’s like anything
else, that they will stop working, that’s why I
don’t like to take so many.’ (P2, female, 65)
Theme 4: trust in healthcare professionals
Positive existing relationship with
HCPs
Positive perceptions that patients have about their
relationship with HCPs, including previous experience of
care by GPs and pharmacists, as well as positive
experiences of care during their recent hospital stay.
‘The doctors and the hospital have been very
good, because I have been admitted quite a few
times. They don’t turn around and say oh no, not
you again, they do treat me as a new patient
every time.’ (P2, female, 65)
Willingness to take antibiotics Specific discussions about being happy to take antibiotic
medications in hospital, particularly as this is often life-
saving and not always viewed as a ‘choice’ if patients want
to recover.
‘I understand the risk you have to take, but if
you’re in a situation like I was, where it was life
and death, you’re going to take a chance of
taking antibiotics, because if I hadn’t taken them
I would have died.’ (P7, male, 62)
Positive perceptions of HCPs as
experts
Perception of HCPs as experts giving each patient the best
possible treatment. Patients discussed being happy to
follow expert HCP advice about antibiotic treatment,
including treatment duration, changes to treatment, and
not always needing to feel involved in initial antibiotic
treatment decisions.
‘I’d be quite happy to accept whatever a doctor
prescribed for me, because they’re the experts
and I am not.’ (P6, female, 91)
Mowbray et al. Pilot and Feasibility Studies            (2020) 6:43 Page 7 of 12
participants spoke positively about revisions to their pre-
scriptions, often mentioning that HCPs had taken time to
clearly explain and inform them about these decisions:
They upped the dosage frequency, and I think they
needed to wait to check because they said we’re
giving you a wide-ranging one, but they may need
to adapt it…and the dose had changed and it had
been explained to me why. (patient 15, female, 50)
Overall, participants reported perceiving the ‘review
and revise’ process to be sensible and felt that their
experiences matched the description provided by the
leaflet. In some cases, participants even felt that the leaf-
let had helped them to make sense of their experiences.
Existing knowledge of antibiotics and resistance
All participants had some knowledge of antibiotics and
antibiotic resistance and many had past experience of
antibiotic treatment. Often this had been a positive ex-
perience, both in terms of the prescribing process and
the efficacy of treatment, but several participants had
previously experienced problems, reporting that certain
drugs were less effective or produced side effects.
Among those who had more negative experiences, there
was still a general feeling of acceptance that they were
being prescribed antibiotics because they were the most
suitable treatment:
I agree that some antibiotics aren’t great and I know
in the past I’ve had some that upset my stomach and
had to stop or change them…but I still think you
need to take them if you’re that ill and sometimes
that outweighs the side effects, and sometimes they
can give you something to counteract a side effect.
(patient 1, female, 50)
Based both on past experience and references to the
media, most participants displayed some knowledge of
antibiotic resistance. Although they were not necessarily
aware of the mechanisms of how resistance works, there
was a general awareness that resistance is a cause for con-
cern and may result in less effective future treatment:
If you use it too much it won’t necessarily work when
you do need it, you know? (patient 14, female, 83)
While participants voiced concerns about growing re-
sistance to antibiotic treatments, these appeared to be
mitigated by understanding that their current treatment
was a necessity. Although they were keen to avoid future
resistance and reported that they would be happy to re-
duce their use of antibiotics if possible, they perceived
antibiotics as having been prescribed to combat a ser-
ious, often life-threatening, health condition.
Trust in healthcare professionals
All participants spoke positively about their relationship
with HCPs, both in relation to routine care provided by
their general practitioner (GP), or their recent care while
in hospital. The majority of participants reported being
given information about their treatment and condition
and being offered the opportunity to ask any questions.
Even among participants who had been unaware of the
initial prescription, there was a feeling that they had
been provided with details about their care as soon as
they were in a state to respond to the information. Des-
pite the chance to ask questions, most participants re-
ported that they did not do this as they had either
already been given the information they needed, or their
condition was improving and they did not have any con-
cerns. Overall, participants appeared to place a large
amount of trust in HCPs. There was a sense that HCPs
were seen as experts who had patient care as their main
priority. This trust in HCPs appeared to mitigate any
concerns that participants might have about their treat-
ment, as they were willing to follow expert advice even if
it meant changing or stopping an antibiotic prescription:
I put my faith in them, that’s fine. If they stop they
stop, I’m quite happy. They said ‘do you mind if we
stop them’, so I thought no, you want them stopped,
stop them. (patient 5, male, 77)
Several participants explained that although they were
happy to be given information about their treatment,
they understood that often they did not have a real
‘choice’ about taking antibiotics if they wanted to re-
cover. Overall, there was a pervasive sense among partic-
ipants that antibiotics had only been prescribed for them
because they were really needed.
Discussion
This study offers novel insights into how patients in
secondary care are likely to respond positively to
messages advocating a reduction in the use of antibi-
otics through the ‘review and revise’ approach. Within
our participant group, the information leaflet was
viewed as both acceptable and useful without causing
undue concern. Individuals reported positive experi-
ences regarding antibiotic prescription being changed
and stopped. Many participants had prior experience
or knowledge of antibiotics and resistance, and gener-
ally welcomed efforts to reduce antibiotic usage.
There was an overall feeling among participants that
HCPs were trusted experts who were providing the
most appropriate treatment for their condition.
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Opportunities for improving patient communication and
engagement with ‘review and revise’
Our findings suggest that informative and balanced mes-
sages are useful in helping patients understand and
accept the ‘review and revise’ antibiotic prescribing
process. Communicators can ensure that antibiotic mes-
saging is effective in a number of ways. First, messages
should incorporate evidence-based information, particu-
larly in relation to antibiotic resistance and the safety
and effectiveness of shorter courses of antibiotic treat-
ment [23]. Additionally, they should address common
patient misperceptions about the mechanisms of resist-
ance. Previous research has shown that patients appear
to view antibiotic resistance as a wider public health
threat, rather than a personal one, particularly if they
have not taken antibiotics regularly themselves, because
they do not see it as something that is transferrable to
others [24, 25]. The current study builds on these findings
by including a message about how antibiotic resistance
can be passed on to family, friends and even pets. Al-
though some patients had questions or concerns about
this process and expressed a desire to avoid antibiotic
treatment if possible, none reported that they would re-
fuse antibiotic treatment if it had been deemed necessary
by an HCP. This suggests that clear and open messages
about the spread of resistance may act as welcome and
important motivators for the acceptance of the ‘review
and revise’ prescribing process among patients.
The long standing and widely held belief that it is
important to complete a course of antibiotics to pre-
vent AMR was clearly evident in the current study
[24, 26]. This has been challenged by evidence showing
that antibiotic treatment courses are often excessive for
individual patients [23] and analyses suggesting the belief
contributes to overuse of antibiotics and increases selec-
tion for AMR [27]. Our study explored reactions to mes-
saging that implicitly suggested that a course of antibiotic
treatment may not always need to be completed and
found that patients accepted this idea. It may be that these
findings are specific to our patient population who had
been recently and acutely ill and not always fully aware of
all aspects of their treatment. For instance, unlike primary
care, a patient in secondary care may be aware that they
are receiving antibiotics, but not necessarily the dosage or
the length of their initial prescription. While in hospital,
patients are closely monitored by HCPs and changes to
treatments may be expected during this time. As a result,
patients within secondary care may be more open to dis-
cussing and accepting changes to their antibiotic treat-
ment. Primary care research in this area has developed
strategies to reduce initial prescribing of unnecessary anti-
biotic courses [28, 29], having shown that antibiotic pre-
scribing increases patient intentions to seek medical care
for future illness, compared to either not prescribing, or
delayed prescribing [30, 31]. This indicates that antibiotic
prescribing decisions can have longer-term effects on
health seeking behaviour, although the potential and feasi-
bility of ‘review and revise’ strategies to reduce overuse of
antibiotic in secondary care, and how to most effectively
communicate this to patients, has not been investigated.
Given the positive patient reactions to the concept of ‘re-
view and revise’ within the current study, it may be benefi-
cial to explore how this could potentially facilitate shared
clinician-patient decision making.
Our study also highlights the importance of testing
messages with the target audience. During the develop-
ment of our information leaflet, we addressed a number
of questions from HCPs and the ethics committee as to
the usefulness and responsibility of providing such infor-
mation to patients. There was some uncertainty about
whether patients would actually want an information
leaflet and whether it might cause or increase any con-
cerns about antibiotic treatment or resistance. Our find-
ings build on existing research, which has shown that
patients within secondary care are keen to receive pro-
active rather than reactive information about antimicro-
bials, allowing them to feel more confident and invested
in their care [17]. While HCPs may worry about patient
reactions, there is a growing body of evidence to suggest
that shared decision-making between patient and HCP
could have a role to play in educating patients about
antimicrobial stewardship and reducing the inappropri-
ate use of antibiotics [32, 25]. There is also an extensive
body of literature examining the relationship of trust be-
tween patient and HCP and the impact this has on ele-
ments such as patient satisfaction and treatment
adherence [33, 34]. Our findings are in line with earlier
research which shows that secondary care patients place
a high level of trust in HCPs and are confident in their
ability to prescribe antibiotics accurately and only when
necessary [25, 35]. This trust in HCPs combined with
the documented want for information and greater pa-
tient engagement [17, 35] suggests that patients are open
and receptive to messages about the ‘review and revise’
process. Additionally, our findings are consistent with
recent research indicating that patients may find it
reassuring to be able to share antibiotic treatment infor-
mation with family [35]. Further research into the timing
of messages may also be useful as preferences may vary
by clinical population or setting and could alter accept-
ability. By testing the key components of messaging with
target populations, we have the best chance of ensuring
maximum effectiveness, while reducing any uninten-
tional, negative impacts [36].
Finally, this study has helped to provide some recom-
mendations for how the leaflet can be best used in the
main trial. First, the main trial should make use of the
final, updated version of the leaflet, as this was
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developed based on the patient feedback as detailed in
this paper. Second, study sites in the main trial should
aim to have a clear plan in place detailing both who will
be distributing the leaflet and when it should be pro-
vided to the patient. The current study indicated that a
lack of time and resources can make it challenging to
find a member of staff to distribute the leaflet. As a re-
sult, the main study sites may find it useful to address
this in their planning to determine the timing and staff-
ing that would be most feasible for their site. Finally,
where it is not possible to find the resources or staffing
to distribute a leaflet, main trial sites could consider pro-
viding the leaflet in another format, such as a poster that
is displayed on the wards. Although this may be a less
optimal format, it may still help to provide patients ac-
cess to information that they are keen to receive.
Strengths and limitations
This in-depth, qualitative study of antibiotic prescribing
within secondary care has helped to highlight key
themes that should be considered when designing future
studies, but it does have some limitations. Recruitment
proved challenging due to many participants having
been hospitalised for serious health conditions. Although
these conditions had improved by the time of discharge
and recruitment to the study, often participants were
still feeling unwell and in some cases were readmitted to
hospital before an interview could take place. As a result,
we may have missed a unique set of experiences related
to the ‘review and revise’ process among those partici-
pants who perhaps went on to receive further antibiotic
treatment, which could have altered their perceptions of
the process. It would have been preferable to conduct
interviews face to face with participants as this could po-
tentially have yielded more in-depth responses; however,
this was not practical for this study because of the neces-
sary restrictions around the recruitment process. In
addition, due to the unavoidable delay between partici-
pant recruitment and interview, not all participants still
had a copy of the leaflet by the time of interview. Al-
though every effort was made to ensure that they had
the leaflet by sending a replacement copy by post or
email, in 1 case this was not possible, and the researcher
decided to read the text over the phone rather than po-
tentially lose the study participant. As a result, it is im-
portant to consider that this could have had an impact
on the responses of that participant; however, they still
provided valuable feedback about the leaflet and their
overall experiences. It is also important to note that re-
sults of the current study are specific to patients within
an acute medical unit in a UK secondary care setting
and therefore, may not be generalisable to other popula-
tions outside the UK or in primary care, where there
may be a very different set of clinical issues. While this
feasibility study had only one hospital site, the main trial
includes 36 sites from healthcare trusts across England,
Wales, Scotland and Northern Ireland. Due to the differ-
ing characteristics of these varied regions, it is likely that
other issues may arise that were not evident within this
feasibility study. These may include elements such as the
practicalities of who should give the leaflet to patients,
when the leaflet should be provided and whether there is
sufficient budget to print the leaflet. We would suggest
that it would be useful for the main trial to further
understand how and if a patient information leaflet ad-
vocating the ‘review and revise’ process might be per-
ceived among other hospital populations, e.g. non-acute
medical ward. It would also be beneficial to consider
how a more diverse patient population across different
ages and ethnicities may react to the leaflet as part of
the main trial. Finally, it is possible that there may be
some response bias among participants who may have
felt obliged to provide positive responses regarding their
perceptions and experiences.
Conclusions
Secondary care patients responded positively to clear,
factual information about antimicrobials and were keen
to receive an information leaflet about antibiotic pre-
scribing and the ‘review and revise’ process. Messages
and information about antibiotic treatment coming from
HCPs were seen as welcome and trustworthy, as well as
being in the best interest of the patient. As such, encour-
aging HCPs within secondary care to engage patients in
greater communication and information provision could
provide great advantages in the drive to reduce antibiotic
use. Pre-testing messages about antibiotic prescribing
and resistance is vital to dispelling any misconceptions
either around effectiveness of treatment for patients, or
perceptions of how messages may be received. Although
it is not feasible to pre-test all messages, for all popula-
tions, it remains important to test key components of
messaging in order to ensure maximum optimisation
and intervention effectiveness.
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